中国临床药学杂志

参考文献

[1]Molavi B,Rassouli N,Bagwe S,et al.A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications[J].Vase Health Risk Manage,2007,3(6):967.

[2]Di Gregorio GB,Yao-Borengasser A,Rasouli N,et al.Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues:association with cytoline expression,insulin resistance, and reduction by pioglitazone[J].Diabetes,2005,54(8):2305.

[3]Unger RH.Minireview:weapons of lean body mass destruction:the role of ectopic lipids in the metabolic syndrome[J].Endocrinology,2003,144 (12):5159.

[4]Friedman J.Fat in all the wrong places[J].Nature,2002,415(6869): 268.

[5]Houstis N,Rosen ED,Lander ES.Reactive oxygen species have a causal role in multiple forms of insulin resistance[J].Nature,2006,440 (7086):944.

[6]Nishikawa T,Edelstein D,Du XL,et al.Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage[J]. Nature,2000,404(6779):787.

[7]Madamanchi NR,Runge MS.Mitochondrial dysfunction in atherosclerosis [J].Cire Res,2007,100(4):460.

[8]Hotamisligil GS.Role of endoplasmic reticulum stress and c-jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes [J].Diabetes,2005,54(12):73.

[9]邹大进.针对2型糖尿病病理生理缺陷尽早开始有效联合治疗[N/OL].中国医学论坛报,2008-07-24[2008-11-10].http://www. cmt.com.cn/article/080724/a080721c1101.htm.

[10]Stolar MW.Insulin resistance,diabetes,and the adipocyte[J].AmJ Health Syst Pharrn,2002,59(9):3.

[11]Otto M,Bremholt J,Westergaard N.Metformin inhibits glycogen synthesis and glyconeogensis in cultured rat hepatocytes[J].Diabetes Obes Metab,2003,5(3):189.

[12]Owen MR,Doran E,Halestrap AP.Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain[J].Biochem,2000,348(Pt 3):607.

[13]Ysuda N,Inoue T,Nagakura T,et al.Enhanced secretion of glucagons like peptide I by biguanide compounds[J].Biochem Biophys Res Commum, 2002,298(5):779.

[14]Valensi P,Behar A,Cohen Boulakiu F.In vivo kinetics of 123 iodinelabelled insulin in skeletal muscle of patients with type 2 diabetes.effect of metformin[J].Diabetes Metab,2002,28(2):95.

[15]Gunton JE,Delhanty PJ,Takahazh S,et al.Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2[J].J Clin Endocrinol Metab, 2003,88(3):133.

[16]Luna V,Cazowban L,Sajan MP,et al.Metformin improves a typical protein kinase C activation by insulin and phosphatidylinosito -3,4,5- (PO4)3 in muscle of diabetic subjects[J].Diabetologia,2006,49(2): 375.

[17]Ascic-Buturovic B.The effect of combined insulin and metformin therapy in obese patients with diabetes mellitus type 2 in the early stage of the disease[J].Bosn J Basi Med Sci,2006,6(2):54.

[18]Mogul HR,Peterson SJ,Weinstein BJ.Metformin and carbohydratemodified diet,a novel obesity protocol:preliminary findings from a case series of nondiabetic women with midlife weight gain and hyperinsulinemia [J].Heart Dis,2001,3(5):285.

[19]Lupi R,Del Guerna S,Fiernbracci V.Lipotoxicity in human pancreatic islets and the protective effect of metformin[J].Diabetes,2002,51(1): 134.

[20]Zhou G,Myers R,Li Y,et al.Role of AMP-activated protein kinase in mechanism of metformin action[J].J Clin Invest,2001,108(8):1167.

[21]Legtenberg RJ,Houston RJ,Qeseburg B,et al.Metformin improves cardiac functional recovery after ischemia in rats[J].Horm Metab Res, 2002,34(4):182.

[22]Stepensky D,Firedrman M,Tay I,et al.Pharmacokinetic-pharmacodynamic analysis of the glucose lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect[J].Drug Metab Dispos, 2002,30(8):861.

[23]Setter SM,Iltz JL,Thams J,et al.Metformin hydrochloride of type 2 diadetes mellitus:a clinical review with a focus on dual therapy[J].Clin Ther,2003,25(12):2991.

[24]Cheng CL,Yu LX,Lea HL,et al.Biowaiver extension potential to BCS classⅢhigh solubility-low permeability drug:bridging evidence for metformin immediate-release tablet[J].Fur J Pharm Sci,2004,22 (4):297.

[25]Hu LD,Liu Y,Tang X,et al.Preparation and in vitor/in vivo evaluation of sustained-release metformin hydrochloride pellets[J].Eur J Pharm Biopharm,2006,64(2):185.

[26]Fujioka K,Pans M,Joyal S.Glycernic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once daily extended-release formulation[J].Clin Ther,2003,25 (2):515.